MindfulGarden
The first clinically validated biofeedback platform for hospital acquired delirium.
| USD | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| % growth | - | - | (33 %) |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
MindfulGarden is a healthcare technology company focused on developing an evidence-based behavior modification platform. The platform aims to de-escalate anxiety and aggression in patients with chronic diseases, particularly those experiencing hospitalized delirium and hyperactive dementia in long-term care settings. Utilizing a videogame engine, the platform responds to patients' agitated voices and gestures, displaying calming computer-generated imagery to mitigate disruptive behaviors. This innovative approach reduces the need for drugs and physical restraints, thereby lowering the cost of care by shortening hospital stays and minimizing the need for close monitoring by staff.
MindfulGarden primarily serves institutional care settings, including hospitals and long-term care facilities. The company operates in the healthcare technology market, targeting a niche segment focused on behavioral health interventions for chronic disease management. Its business model revolves around the commercialization of its platform, generating revenue through sales and licensing agreements with healthcare institutions.
Keywords: behavior modification, chronic disease, anxiety, aggression, hospitalized delirium, hyperactive dementia, long-term care, videogame engine, healthcare technology, cost reduction.